Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
This novel four-step synthetic route for Sitagliptin significantly reduces production costs and enhances optical purity for reliable API intermediate supply chains globally.
Novel halogenation-fluorination route for 5-fluoro-2-hydroxyacetophenone. High yield, low waste, scalable process for beta-blocker intermediates.
Patent CN113968775A reveals a safe, scalable route for 4-chloro-2-trifluoromethyl-acetophenone intermediates, eliminating dangerous Grignard reactions for reliable agrochemical supply.
Novel synthesis route for Montelukast Sodium intermediates via CN102424673B. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN107353221A details a novel Pd-catalyzed synthesis for high-purity chiral intermediates. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Novel m-fluoroaniline route for Hepatitis C intermediate. High yield, low cost, scalable process for global pharma supply chains.
Patent CN107325002A details a green silver-catalyzed decarboxylative halogenation route. This method offers cost reduction in pharma intermediate manufacturing and enhanced supply chain reliability.
Patent CN113024399A details a novel Duff reaction route for high-purity Telmisartan intermediates, offering significant cost reduction and scalable production capabilities.
Novel photocatalytic process for Vitamin A Palmitate ensures high purity and continuous production efficiency for global supply chains.
Patent CN114105858B reveals green electrochemical route for 3-azidoindoline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN104016974A details a novel synthetic route for Azilsartan medoxomil intermediates, offering high purity and significant cost reduction opportunities for pharmaceutical manufacturing supply chains.
Discover a novel 3-step synthesis for Lenalidomide intermediates using glutarimide. Achieve high purity and significant cost reduction in pharma manufacturing with scalable routes.
Patent CN115368217A details a novel synthesis of 3,4,5-trimethoxytoluene for CoQ10 production, offering significant cost reduction and environmental benefits.
Novel regioselective coupling process for LRRK2 inhibitors offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN114044813B details high-yield procatide preparation offering supply chain stability and significant cost reduction in API manufacturing for global partners.
Patent CN100355733C details a scalable 3-step route for 2-chloro-5-fluoro-nicotinic acid, eliminating toxic thiols and enabling cost-effective pharmaceutical intermediate manufacturing.
Novel chiral catalyst method reduces cost and complexity in sitagliptin manufacturing, ensuring high purity and supply chain stability for global pharmaceutical partners.
Patent CN116121310A reveals a high-efficiency enzymatic route for dexketoprofen, offering superior purity and scalable production for reliable pharmaceutical intermediates suppliers.
Novel pH-controlled hydrogenation method ensures high purity and scalable production for pharmaceutical intermediates supply chains globally reducing costs significantly and improving efficiency.
Patent CN103172522A details a one-step nickel-catalyzed hydrogenation method for diaminodecalin, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.